Zacks Investment Research
29 Jun 2026, 15:45 UTC · 1h ago
Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
29 Jun 2026, 15:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Johnson & Johnson proposed a $1 billion acquisition of Firefly Bio to strengthen its oncology pipeline for KRAS-driven cancers. — Strategic acquisitions in high-growth areas like oncology typically drive long-term value and pipeline expansion.
+0.40The CHMP recommended the approval of Tecvayli in combination with Darzalex SC for treating adult patients with relapsed or refractory multiple myeloma. — Regulatory recommendations for new drug combinations expand the addressable market and revenue potential for existing products.
+0.30Johnson & Johnson is expected to report quarterly revenues of $25.04 billion, a 5.5% increase year-over-year. — Positive revenue growth expectations suggest operational stability and a potential beat on top-line figures.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
Shares hit a 52-week high following a proposed $1 billion acquisition and positive regulatory recommendations for Tecvayli.
The stock closed slightly higher and has a positive monthly return, though earnings estimates were revised marginally lower.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
24/7 Wall Street
3h ago
